Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Donal McLornan; Richard Szydlo; Linda Koster; Yves Chalandon; Marie Robin; Christine Wolschke; Dietrich Beelen; Gerard Socie; Martin Bornhaeuser; Emanuele Angelucci; Dietger Niederwieser; Arnim Gerbitz; Juergen Finke; Antonin Vitek; Maija Itälä-Remes; Aleksandar Radujkovic; Lothar Kanz; Victoria Potter; Patrice Chevallier; Matthias Stelljes; Eefke Petersen; Stephen Robinson; Xavier Poire; Evgeny Klyuchnikov; Juan Carlos Hernandez-Boluda; Tomasz Czerw; Patrick Hayden; Nicolaus Kroeger; Ibrahim Yakoub-Agha

doi:10.1016/j.bbmt.2019.06.034

Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Donal McLornan, Richard Szydlo, Linda Koster, Yves Chalandon, Marie Robin, Christine Wolschke, Dietrich Beelen, Gerard Socie, Martin Bornhaeuser, Emanuele Angelucci, Dietger Niederwieser, Arnim Gerbitz, Juergen Finke, Antonin Vitek, Maija Itälä-Remes, Aleksandar Radujkovic, Lothar Kanz, Victoria Potter, Patrice Chevallier, Matthias StelljesEefke Petersen, Stephen Robinson, Xavier Poire, Evgeny Klyuchnikov, Juan Carlos Hernandez-Boluda, Tomasz Czerw, Patrick Hayden, Nicolaus Kroeger, Ibrahim Yakoub-Agha

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Biology of Blood and Marrow Transplantation
Volume	25
Issue number	11
Pages (from-to)	2167-2171
Number of pages	5
ISSN	1083-8791
DOIs	https://doi.org/10.1016/j.bbmt.2019.06.034
Publication status	Published - Nov 2019
MoE publication type	A1 Journal article-refereed

Fields of Science

Myeloproliferative
Stem cell transplantation
Reduced intensity
Myeloablative
RUXOLITINIB
3122 Cancers

Access to Document

10.1016/j.bbmt.2019.06.034

Cite this

McLornan, D., Szydlo, R., Koster, L., Chalandon, Y., Robin, M., Wolschke, C., Beelen, D., Socie, G., Bornhaeuser, M., Angelucci, E., Niederwieser, D., Gerbitz, A., Finke, J., Vitek, A., Itälä-Remes, M., Radujkovic, A., Kanz, L., Potter, V., Chevallier, P., ... Yakoub-Agha, I. (2019). Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 25(11), 2167-2171. https://doi.org/10.1016/j.bbmt.2019.06.034

McLornan, Donal ; Szydlo, Richard ; Koster, Linda et al. / Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis : A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. In: Biology of Blood and Marrow Transplantation. 2019 ; Vol. 25, No. 11. pp. 2167-2171.

@article{0582a0a15d2940c09f1b0e45579a5876,

title = "Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation",

keywords = "Myeloproliferative, Stem cell transplantation, Reduced intensity, Myeloablative, RUXOLITINIB, 3122 Cancers",

author = "Donal McLornan and Richard Szydlo and Linda Koster and Yves Chalandon and Marie Robin and Christine Wolschke and Dietrich Beelen and Gerard Socie and Martin Bornhaeuser and Emanuele Angelucci and Dietger Niederwieser and Arnim Gerbitz and Juergen Finke and Antonin Vitek and Maija It{\"a}l{\"a}-Remes and Aleksandar Radujkovic and Lothar Kanz and Victoria Potter and Patrice Chevallier and Matthias Stelljes and Eefke Petersen and Stephen Robinson and Xavier Poire and Evgeny Klyuchnikov and {Carlos Hernandez-Boluda}, Juan and Tomasz Czerw and Patrick Hayden and Nicolaus Kroeger and Ibrahim Yakoub-Agha",

year = "2019",

month = nov,

doi = "10.1016/j.bbmt.2019.06.034",

language = "English",

volume = "25",

pages = "2167--2171",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC",

number = "11",

}

McLornan, D, Szydlo, R, Koster, L, Chalandon, Y, Robin, M, Wolschke, C, Beelen, D, Socie, G, Bornhaeuser, M, Angelucci, E, Niederwieser, D, Gerbitz, A, Finke, J, Vitek, A, Itälä-Remes, M, Radujkovic, A, Kanz, L, Potter, V, Chevallier, P, Stelljes, M, Petersen, E, Robinson, S, Poire, X, Klyuchnikov, E, Carlos Hernandez-Boluda, J, Czerw, T, Hayden, P, Kroeger, N & Yakoub-Agha, I 2019, 'Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation', Biology of Blood and Marrow Transplantation, vol. 25, no. 11, pp. 2167-2171. https://doi.org/10.1016/j.bbmt.2019.06.034

Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. / McLornan, Donal; Szydlo, Richard; Koster, Linda et al.
In: Biology of Blood and Marrow Transplantation, Vol. 25, No. 11, 11.2019, p. 2167-2171.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis

T2 - A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

AU - McLornan, Donal

AU - Szydlo, Richard

AU - Koster, Linda

AU - Chalandon, Yves

AU - Robin, Marie

AU - Wolschke, Christine

AU - Beelen, Dietrich

AU - Socie, Gerard

AU - Bornhaeuser, Martin

AU - Angelucci, Emanuele

AU - Niederwieser, Dietger

AU - Gerbitz, Arnim

AU - Finke, Juergen

AU - Vitek, Antonin

AU - Itälä-Remes, Maija

AU - Radujkovic, Aleksandar

AU - Kanz, Lothar

AU - Potter, Victoria

AU - Chevallier, Patrice

AU - Stelljes, Matthias

AU - Petersen, Eefke

AU - Robinson, Stephen

AU - Poire, Xavier

AU - Klyuchnikov, Evgeny

AU - Carlos Hernandez-Boluda, Juan

AU - Czerw, Tomasz

AU - Hayden, Patrick

AU - Kroeger, Nicolaus

AU - Yakoub-Agha, Ibrahim

PY - 2019/11

Y1 - 2019/11

KW - Myeloproliferative

KW - Stem cell transplantation

KW - Reduced intensity

KW - Myeloablative

KW - RUXOLITINIB

KW - 3122 Cancers

U2 - 10.1016/j.bbmt.2019.06.034

DO - 10.1016/j.bbmt.2019.06.034

M3 - Article

SN - 1083-8791

VL - 25

SP - 2167

EP - 2171

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 11

ER -

McLornan D, Szydlo R, Koster L, Chalandon Y, Robin M, Wolschke C et al. Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation. 2019 Nov;25(11):2167-2171. doi: 10.1016/j.bbmt.2019.06.034